ATRA CIK: 1604464

Atara Biotherapeutics, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
billions USD
FY21:
0.38
FY22:
0.30
FY23:
0.10
FY24:
0.06
FY25:
0.01
(positive)
Change from FY21 to FY25
billions USD
FY21:
0.08
FY22:
0.08
FY23:
0.06
FY24:
0.04
FY25:
0.01
Total assets
Change from FY21 to FY25
billions USD
FY21:
0.47
FY22:
0.38
FY23:
0.17
FY24:
0.11
FY25:
0.02

Liabilities & Equity

(negative)
Change from FY21 to FY25
billions USD
FY21:
0.11
FY22:
0.08
FY23:
0.14
FY24:
0.13
FY25:
0.01
(negative)
Change from FY21 to FY25
billions USD
FY21:
0.08
FY22:
0.17
FY23:
0.12
FY24:
0.07
FY25:
0.04
(positive)
Change from FY21 to FY25
billions USD
FY21:
0.28
FY22:
0.13
FY23:
−0.10
FY24:
−0.10
FY25:
−0.04
Total liabilities & equity
Change from FY21 to FY25
billions USD
FY21:
0.47
FY22:
0.38
FY23:
0.17
FY24:
0.11
FY25:
0.02

All amounts in billions USD Data sources:SEC EDGARTwelve Data